The Valley Desk

NCT06537414 · Interventional trial

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

Overall registry status Active not recruiting

Phase 2

Conditions Chronic Hepatitis B Virus Infection, Hepatitis B

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov